Skip to main content

Table 1 Baseline and metabolic parameters T2DM patients with or without metabolic syndrome and the normal controls

From: Metabolic syndrome and myocardium steatosis in subclinical type 2 diabetes mellitus: a 1H-magnetic resonance spectroscopy study

  Normal (n = 20) Non-MetS (n = 23) MetS (n = 30)
Baseline characteristics
 Age (y) 50.95 ± 10.185 54.85 ± 10.87 54.48 ± 9.61
 Male (n) 10(50.0%) 15(65.2%) 16(53.3%)
 High (cm) 162.70 ± 7.08 162.85 ± 9.23 164.13 ± 7.29
 Weigh (kg) 61.30 ± 5.96 58.52 ± 8.22 66.54 ± 8.55*β
 BMI 23.14 ± 1.49 22.03 ± 2.30 24.71 ± 3.05β
 Systolic blood pressure (mmHg) 119.45 ± 7.22 130.36 ± 16.86 132. ± 19.22*
 Diastolic blood pressure (mmHg) 78.75 ± 7.81 76.42 ± 7.67 80.09 ± 10.53
 Duration of diabetes (y) 7.32 ± 7.24 7.90 ± 4.59
 Waist circumference (cm) 83.33 ± 5.79 93.37 ± 1.05
Metabolic characteristics
 HbA1c (%) 5.38 ± 0.34 6.47 ± 2.87* 6.75 ± 2.76*
 GLU (mmol/l) 5.07 ± 0.43 7.11 ± 5.12* 5.70 ± 3.94
 TG (mmol/l) 1.03 ± 0.27 1.14 ± 0.41 1.76 ± 1.64*
 TC (mmol/l) 4.30 ± 0.57 4.29 ± 0.86 4.59 ± 0.83
 HDL (mmol/l) 1.31 ± 0.28 1.47 ± 0.34 1.23 ± 0.36
 LDL (mmol/l) 2.71 ± 0.53 2.36 ± 0.73 2.70 ± 0.74
 Creatinine (μmol/l) 66.20 ± 12.59 73.97 ± 22.15
 GFR (30 ml/min) 99.84 ± 10.32 95.85 ± 19.17
 AST (U/l) 23.00 ± 12.07 25.58 ± 15.82
 ALT (U/l) 24.53 ± 8.94 23.04 ± 8.94
 Uric acid (μmol/l) 340.00 ± 37.04 331.81 ± 60.49 359.88 ± 95.95
Medication, n (%)
 Insulin 7 (33%) 10 (31%)
 Metformin 11 (52%) 19 (59%)
 Sulfonylurea 2 (9%) 9 (28%)
 α-Glucosidase inhibitor 5 (24%) 16 (50%)
 ACEI 0 4 (13%)
 Statin 2 (9%) 7 (22%)
  1. The values are the mean ± SD. BMI body mass index, HbA1c glycated hemoglobin, Glu glucose, TG triglycerides, TC triglyceride, HDL highdensity lipoprotein cholesterol, LDL low-density lipoprotein cholestero, GFR glomerular filtration rate, AST aspartate transaminase, ALT alanine transaminase
  2. *P < 0.017 versus normal group
  3. βP < 0.017 versus T2DM in non-MetS group